BackgroundCheck.run
Search For

Charles S Huang, 349497 High Park Ln, San Diego, CA 92129

Known as:
Charles W Huang Chin Shan Huang Chin Cheong Hwa Huang Chin Cheong Huang Chin S Huang Huai C Huang Caroline H Huang Shan Huang Cheong Hwa Huang Cheong
Related to:
Shu U Huang 46

Charles Huang Phones & Addresses

San Diego, CA   

Chicago, IL   

Encinitas, CA   

Albany, CA   

1300 Midvale Ave, Los Angeles, CA 90024    310-2315123   

1300 Midvale Ave #308, Los Angeles, CA 90024    310-2315123   

527 Midvale Ave, Los Angeles, CA 90024    310-2098259   

Davis, CA   

Get Report
Control this profile

Mentions for Charles S Huang

Career records & work history

Real Estate Brokers

Charles Huang Photo 1

Ex-Appraiser, Real Estate And Mortgage Loan Licenses

Specialties:
Buyer's Agent, Listing Agent, Short-Sale, Consulting
Work:
Bay Home Investments and Loans Inc.
3958 Valley Ave, Suite B, Pleasanton, CA 94580
510-3641179 (Office), 925-9808868 (Cell), 877-5852728 (Fax)
Experience:
13 years
Licenses:
01517783 (Real Estate and Mortgage Loan Licenses)
Languages:
Cantonese
Mandarin
Links:
Site

Medicine Doctors

Charles Huang Photo 2

Dr. Charles Q Huang, Pleasanton CA - MD (Doctor of Medicine)

Specialties:
Ophthalmology
Address:
CHARLES QING HUANG
7601 Stoneridge Dr, Pleasanton, CA 94588
707-4535600 (Phone)
Certifications:
Ophthalmology, 2008
Awards:
Healthgrades Honor Roll
Languages:
English
Spanish
Hospitals:
CHARLES QING HUANG
7601 Stoneridge Dr, Pleasanton, CA 94588
Kaiser Permanente Vallejo Medical Center
975 Sereno Drive, Vallejo, CA 94589
Kaiser Permanente Walnut Creek Medical Center
1425 South Main Street, Walnut Creek, CA 94596
Education:
Medical School
University of California At Irvine / California College of Medicine & Surgery
Graduated: 2003
Charles Huang Photo 3

Dr. Charles L Huang, Chicago IL - MD (Doctor of Medicine)

Specialties:
Diagnostic Radiology
Address:
2525 S Michigan Ave, Chicago, IL 60616
MERCY HOSPITAL
2525 S Michigan Ave Suite 8Th, Chicago, IL 60616
312-5672795 (Phone) 773-9352861 (Fax)
2929 S Ellis Ave, Chicago, IL 60616
312-7912000 (Phone)
Certifications:
Diagnostic Radiology, 2005
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Northwestern Center Feinberg School of Medicine
Graduated: 2000
Medical School
Albert Einstein Med Center
Graduated: 2000
Medical School
University Il College Of Med
Graduated: 2000
Medical School
Rush University and Medical Center
Graduated: 2000
Charles Huang Photo 4

Dr. Charles Huang, Los Angeles CA - DDS (Doctor of Dental Surgery)

Specialties:
Dentistry
Address:
404 S Figueroa St Suite 207, Los Angeles, CA 90071
Languages:
English

Charles S. Huang

Specialties:
Pain Management, Physical Medicine & Rehabilitation
Work:
Charles S Huang DO
5147 S Lakeland Dr STE 2, Lakeland, FL 33813
863-9404750 (phone) 863-9404753 (fax)
Education:
Medical School
Nova Southeastern University College of Osteopathic Medicine
Graduated: 1994
Procedures:
Neurological Testing, Osteopathic Manipulative Treatment, Physical Therapy
Languages:
English
Description:
Dr. Huang graduated from the Nova Southeastern University College of Osteopathic Medicine in 1994. He works in Lakeland, FL and specializes in Pain Management and Physical Medicine & Rehabilitation.

Charles Q. Huang

Specialties:
Ophthalmology
Work:
Kaiser Permanente Medical GroupKaiser Pleasanton Medical Center Ophthalmology
7601 Stoneridge Dr FL BLDG1, Pleasanton, CA 94588
925-8475788 (phone) 925-8475635 (fax)
Site
Education:
Medical School
University of California, Davis School of Medicine
Graduated: 2003
Procedures:
Corneal Surgery, Lens and Cataract Procedures, Ophthalmological Exam
Languages:
English, Spanish
Description:
Dr. Huang graduated from the University of California, Davis School of Medicine in 2003. He works in Pleasanton, CA and specializes in Ophthalmology. Dr. Huang is affiliated with Kaiser Permanente Oakland Medical Center.
Charles Huang Photo 5

Charles L Huang

Specialties:
Orthopaedic Surgery
Education:
Columbia University (1989)
Charles Huang Photo 6

Charles Qing Huang, Pleasanton CA

Specialties:
Ophthalmology
Work:
Pleasanton Medical Offices
7601 Stoneridge Dr, Pleasanton, CA 94588
Education:
University of California at Davis (2003)
Charles Huang Photo 7

Charles Lee Huang, Chicago IL

Specialties:
Radiologist
Address:
2525 S Michigan Ave, Chicago, IL 60616
2929 S Ellis Ave, Chicago, IL 60616
Education:
Doctor of Medicine
Rush University Medical Center - Fellowship - Neuroradiology
Board certifications:
American Board of Radiology Certification in Diagnostic Radiology (Radiology)

License Records

Charles Lee Huang Md

Address:
Chicago, IL 60616
Licenses:
License #: 125043116 - Expired
Expiration Date: Jun 30, 2004
Type: Temporary Medical Permit
License #: 036111898 - Active
Issued Date: Jul 20, 2004
Expiration Date: Jul 31, 2017
Type: Licensed Physician And Surgeon
License #: 336074439 - Active
Issued Date: May 20, 2005
Expiration Date: Jul 31, 2017
Type: Licensed Physician Controlled Substance(Schedules Ii Iii Iv V )

Charles Lee Huang Md

Address:
Chicago, IL 60616
Licenses:
License #: 336074439 - Active
Issued Date: May 20, 2005
Expiration Date: Jul 31, 2017
Type: Licensed Physician Controlled Substance(Schedules Ii Iii Iv V )
License #: 036111898 - Active
Issued Date: Jul 20, 2004
Expiration Date: Jul 31, 2017
Type: Licensed Physician And Surgeon
License #: 125043116 - Expired
Issued Date: Jul 1, 2001
Expiration Date: Jun 30, 2004
Type: Temporary Medical Permit

Charles Lee Huang

Licenses:
License #: MT047526T - Expired
Category: Medicine
Type: Graduate Medical Trainee

Publications & IP owners

Us Patents

Crf Antagonistic Quino- And Quinazolines

US Patent:
6482836, Nov 19, 2002
Filed:
Oct 19, 1999
Appl. No.:
09/403393
Inventors:
Charles Huang - San Diego CA, 92129
Keith M. Wilcoxen - San Diego CA, 92103
Chen Chen - San Diego CA, 92129
Mustapha Haddach - San Diego CA, 92108
James R. McCarthy - San Diego CA, 92075
International Classification:
A61K 314706
US Classification:
514313, 514314, 514311, 546159, 546152, 546176
Abstract:
This invention concerns compounds of formula including the stereoisomers and the pharmaceutically acceptable acid addition salt forms thereof, wherein R is C alkyl, NR R , OR or SR ; R is hydrogen, C alkyl, C alkyloxy or C alkylthio; R is Ar or Het ; R and R are each independently selected from hydrogen, halo, C alkyl, C alkyloxy, trifluoromethyl, cyano, nitro, amino, and mono- or di(C alkyl)amino; R is hydrogen, C alkyl, C alkylsulfonyl, C alkylsulfoxy or C alkylthio; R is hydrogen, C alkyl, mono- or di(C cycloalkyl)methyl, C cycloalkyl, C alkenyl, hydroxyC alkyl, C alkylcarbonyloxy-C alkyl or C alkyloxyC alkyl; R is C alkyl, mono- or di(C cycloalkyl)-methyl, Ar CH , C alkyloxyC alkyl, hydroxyC alkyl, C alkenyl, thienylmethyl, furanylmethyl, C alkylthioC alkyl, mono- or di(C alkyl)aminoC alkyl, di(C alkyl)amino, C alkylcarbonylC alkyl; or R and R taken together with the nitrogen atom to which they are attached may form a pyrrolidinyl, piperidinyl, homopiperidinyl or morpholinyl group, optionally substituted with C alkyl or C alkyloxyC alkyl; and Ar and Ar are each optionally substituted phenyl; and Het is optionally substituted pyridinyl; having CRF receptor antagonistic properties; pharmaceutical compositions containing such compounds as active ingredients; methods of treating disorders related to hypersecretion of CRF such as depression, anxiety, substance abuse, by administering an effective amount of a compound of formula (I).

Crf Receptor Antagonists And Methods Relating Thereto

US Patent:
6514982, Feb 4, 2003
Filed:
Nov 12, 1999
Appl. No.:
09/439840
Inventors:
Mustapha Haddach - San Diego CA
Brian P. Dyck - San Diego CA
Charles Q. Huang - San Diego CA
Jodie Nelson - San Diego CA
Zhiqiang Guo - San Diego CA
James R. McCarthy - Zionsville IN
Assignee:
Neurocrine Biosciences, Inc. - San Diego CA
International Classification:
C07D48704
US Classification:
514267, 5142328, 514241, 51425202, 514259, 51425204, 514292, 51425216, 514256, 51425303, 514248, 544180, 544115, 544238, 544250, 544251, 544284, 544237, 544333, 544405, 544235
Abstract:
CRF receptor antagonists are disclosed which have utility in the treatment of a variety of disorders, including the treatment of disorders manifesting hypersecretion of CRF in a warm-blooded animals, such as stroke. The CRF receptor antagonists of this invention have the following structure: including stereoisomers and pharmaceutically acceptable salts thereof, wherein n, m, A, B, C, R, R , R and Ar are as defined herein. Compositions containing a CRF receptor antagonist in combination with a pharmaceutically acceptable carrier are also disclosed, as well as methods for use of the same.

Crf Receptor Antagonists And Methods Relating Thereto

US Patent:
6531475, Mar 11, 2003
Filed:
May 18, 2000
Appl. No.:
09/574751
Inventors:
Mustapha Haddach - San Diego CA
Brian P. Dyck - San Diego CA
Charles Q. Huang - San Diego CA
Jodie Nelson - San Diego CA
Zhiqiang Guo - San Diego CA
James R. McCarthy - Zionsville IN
Assignee:
Neurocrine Biosciences, Inc. - San Diego CA
International Classification:
C07D47114
US Classification:
514250, 514241, 5142332, 544115, 544180, 544295, 544235, 544237, 544238, 544284, 544333, 544346, 544251
Abstract:
CRF receptor antagonists are disclosed which have utility in the treatment of a variety of disorders, including the treatment of disorders manifesting hypersecretion of CRF in a warm-blooded animals, such as stroke. The CRF receptor antagonists of this invention have the following structure: including stereoisomers and pharmaceutically acceptable salts thereof, wherein n, m, A, B, C, R, R , R and Ar are as defined herein. Compositions containing a CRF receptor antagonist in combination with a pharmaceutically acceptable carrier are also disclosed, as well as methods for use of the same.

Crf Antagonistic Quino-And Quinazolines

US Patent:
6610678, Aug 26, 2003
Filed:
Oct 8, 2002
Appl. No.:
10/266662
Inventors:
Charles Huang - San Diego CA, 92129
Keith M. Wilcoxen - San Diego CA, 92103
Chen Chen - San Diego CA, 92129
Mustapha Haddach - San Diego CA, 92108
James R. McCarthy - San Diego CA, 92075
International Classification:
A61K 3133
US Classification:
514183, 51421201, 5142312, 51426621, 51426623, 51426631, 5142664, 514315, 540484, 540596, 544106, 544283, 544293, 544298, 544319, 544326, 546184, 546205, 548400, 548518
Abstract:
This invention concerns compounds of formula including the stereoisomers and the pharmaceutically acceptable acid addition salt forms thereof, wherein R is C alkyl, NR R , OR or SR ; R is hydrogen, C alkyl, C alkyloxy or C alkylthio; R is Ar or Het ; R and R are each independently selected from hydrogen, halo, C alkyl, C alkyloxy, trifluoromethyl, cyano, nitro, amino, and mono- or di(C alkyl)amino; R is hydrogen, C alkyl, C alkylsulfonyl, C alkylsulfoxy or C alkylthio; R is hydrogen, C alkyl, mono- or di(C cyclo-alkyl)methyl, C cycloalkyl, C alkenyl, hydroxyC alkyl, C alkylcarbonyloxy-C alkyl or C alkyloxyC alkyl; R is C alkyl, mono- or di(C cycloalkyl)-methyl, Ar CH , C alkyloxyC alkyl, hydroxyC alkyl, C alkenyl, thienylmethyl, furanylmethyl, C alkylthioC alkyl, mono- or di(C alkyl)aminoC alkyl, di(C alkyl)amino, C alkylcarbonylC alkyl; or R and R taken together with the nitrogen atom to which they are attached may form a pyrrolidinyl, piperidinyl, homopiperidinyl or morpholinyl group, optionally substituted with C alkyl or C alkyloxyC alkyl; and Ar and Ar are each optionally substituted phenyl; and Het is optionally substituted pyridinyl; having CRF receptor antagonistic properties; pharmaceutical compositions containing such compounds as active ingredients; methods of treating disorders related to hypersecretion of CRF such as depression, anxiety, substance abuse, by administering an effective amount of a compound of formula (I).

Crf Antagonistic Pyrazolo[4,3-B]Pyridines

US Patent:
6613777, Sep 2, 2003
Filed:
Feb 20, 2001
Appl. No.:
09/623634
Inventors:
Chen Chen - San Diego CA, 92129
Keith M. Wilcoxen - San Diego CA, 92103
Charles Q. Huang - San Diego CA, 92129
James R. McCarthy - Solana Beach CA, 92075
International Classification:
A61K 3144
US Classification:
514303, 546119
Abstract:
This invention concerns compounds of formula including the stereoisomers and the pharmaceutically acceptable acid addition salt forms thereof, wherein R is C alkyl, NR R , OR or SR ; R is C alkyl, C alkyloxy, or C alkylthio; R is Ar or Het ; R is hydrogen or C alkyl; R is hydrogen, C alkyl, mono- or di(C cycloalkyl)methyl, C cycloalkyl, C alkenyl, hydroxyC alkyl, C alkylcarbonyloxyC alkyl, mono- or di(C alkyl)amino-C alkyl or C alkyloxyC alkyl; R is C alkyl, mono- or di(C cycloalkyl)methyl, Ar C alkyl, Ar oxyC alkyl, C alkyloxyC alkyl, hydroxyC alkyl, C alkenyl, thienylmethyl, furanylmethyl, tetrahydrofuranylmethyl, C alkylthioC alkyl, mono- or di(C alkyl)aminoC alkyl, di(C alkyl)amino, or C alkylcarbonylC alkyl; or R and R taken together with the nitrogen atom to which they are attached may form a pyrrolidinyl, piperidinyl, homopiperidinyl, morpholinyl, or thiomorpholinyl group, optionally substituted with 1 or 2 substituents each independently selected from C alkyl or C alkyloxyC alkyl; and and Ar and Ar are each optionally substituted phenyl; and Het is optionally substituted pyridinyl; having CRF receptor antagonistic properties; pharmaceutical compositions containing such compounds as active ingredients; methods of treating disorders related to hypersecretion of CRF such as depression, anxiety, substance abuse, by administering an effective amount of a compound of formula (I).

Pyrazolopyrimidines As Crf Receptor Antagonists

US Patent:
6664261, Dec 16, 2003
Filed:
Mar 2, 1999
Appl. No.:
09/117717
Inventors:
Chen Chen - San Diego CA
Thomas R. Webb - Olivenhain CA
James R. McCarthy - Solana Beach CA
Terence J. Moran - San Diego CA
Keith M. Wilcoxen - Groton Long Point CA
Charles Huang - San Diego CA
Assignee:
Neurocrine Biosciences, Inc. - San Diego CA
International Classification:
A61K 31505
US Classification:
514258, 544250, 544281
Abstract:
This invention concerns compounds of formula including the stereoisomers and the pharmaceutically acceptable acid addition salt forms thereof, wherein R is NR R or OR ; R is C alkyl, C alkyloxy or C alkylthio; R is hydrogen, C alkyl, C alkylsulfonyl, C alkylsulfoxy or C alkylthio; R is hydrogen, C alkyl, mono- or di(C cycloalkyl)methyl, C cycloalkyl, C alkenyl, hydroxyC alkyl, C alkylcarbonyloxyC alkyl or C alkyloxyC alkyl; R is C alkyl, mono- or di(C cycloalkyl)methyl, Ar CH , C alkyloxyC alkyl, hydroxyC alkyl, C alkenyl, thienylmethyl, furanylmethyl, C alkylthioC alkyl, morpholinyl, mono- or di(C alkyl)aminoC alkyl, di(C alkyl)amino, C alkylcarbonylC alkyl, C alkyl substituted with imidazolyl; or a radical of formula âAlkâOâCOâAr ; or R and R taken together with the nitrogen atom to which they are attached may form an optionally substituted pyrrolidinyl, piperidinyl, homopiperidinyl or morpholinyl group; having CRF receptor antagonistic properties; pharmaceutical compositions containing such compounds as active ingredients; methods of treating disorders related to hypersecretion of CRF such as depression, anxiety, substance abuse, by administering an effective amount of a compound of formula (I).

Crf Receptor Antagonists And Methods Relating Thereto

US Patent:
6747034, Jun 8, 2004
Filed:
Nov 2, 2001
Appl. No.:
10/016694
Inventors:
Mustapha Haddach - San Diego CA
Marion C. Lanier - San Diego CA
Charles Q. Huang - San Diego CA
James R. McCarthy - Zionsville IN
Assignee:
Neurocrine Biosciences, Inc. - San Diego CA
International Classification:
A61K 31505
US Classification:
514267, 544251
Abstract:
CRF receptor antagonists are disclosed which have utility in the treatment of a variety of disorders, including the treatment of disorders manifesting hypersecretion of CRF in a warm-blooded animals, such as stroke.

Gonadotropin-Releasing Hormone Receptor Antagonists And Methods Relating Thereto

US Patent:
7015226, Mar 21, 2006
Filed:
Jul 6, 2004
Appl. No.:
10/885490
Inventors:
Charles Q. Huang - San Diego CA, US
Chen Chen - San Diego CA, US
Yongsheng Chen - San Diego CA, US
Zhiqiang Guo - San Diego CA, US
Warren Wade - San Diego CA, US
Martin Rowbottom - San Diego CA, US
Jaimie K. Rueter - San Diego CA, US
Assignee:
Neurocrine Biosciences, Inc. - San Diego CA
International Classification:
C07D 239/54
A61K 31/513
US Classification:
51425214, 514274, 544311
Abstract:
GnRH receptor antagonists are disclosed that have utility in the treatment of a variety of sex-hormone related conditions in both men and women. The compounds of this invention have the structure: wherein n, R, R, R, R, R, R, R, R, Rand X are as defined herein, including stereoisomers, prodrugs and pharmaceutically acceptable salts thereof. Also disclosed are compositions containing a compound of this invention in combination with a pharmaceutically acceptable carrier, as well as methods relating to the use thereof for antagonizing gonadotropin-releasing hormone in a subject in need thereof.

Possible Relatives

Cynthia M Huang  David T Huang  Dawei Huang  Dayong Huang  Da Huang  Daijie D Huang  Daisy Huang  Charles W Johnson  Charles L Stamps  Charles J Stancil 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.